Home Newsfeeds Stephens & Co. Reiterates Overweight on Avid Bioservices, Maintains $22 Price Target

Stephens & Co. Reiterates Overweight on Avid Bioservices, Maintains $22 Price Target

Stephens & Co. analyst Jacob Johnson reiterates Avid Bioservices (NASDAQ:CDMO) with a Overweight and maintains $22 price target.

byBenzinga Newsdesk

March 14, 2023

1 minute read

Stephens & Co. analyst Jacob Johnson reiterates Avid Bioservices (NASDAQ:CDMO) with a Overweight and maintains $22 price target.

What Is A Death Spiral Convertible? Michael Burry Sounds The Alarm For Meme Stock Fans

By AJ Fabino

February 9, 3:45 PM

Michael Burry, the millionaire born out of the subprime mortgage crisis back in 2007 and known for constantly deleting his tweets (and his account), gave meme stock investors a bit of homework.

AMC

Jefferies Assumes National Vision Holdings at Buy, Announces Price Target of $45

By Benzinga Newsdesk

November 7, 10:45 AM

Jefferies analyst Brian Tanquilut assumes National Vision Holdings (NASDAQ:EYE) with a Buy rating and announces Price Target of $45.

EYE

Warner Bros. Discovery Eyes Turnaround with Upcoming Disney+ Bundle and NBA Deal, Analysts Say

By Anusuya Lahiri

May 10, 2:34 PM

Nispel upgraded Warner Bros. Discovery (WBD) from Sector Weight to Overweight with a $11 price target. WBD reported Q1 revenue below consensus, impacted by content impairment. Nispel expects a short-term rally as numbers stabilize and DTC improves. Martin reiterated Hold rating, noting WBD's Max bundle with Disney+ and Hulu launching this summer and potential for larger bundles in the future. Reif Ehrlich maintained Buy rating with $14 price target, citing upcoming catalysts and undemanding valuation. NBA media rights renewal is a key near-term event. WBD's Q1 performance reflects macro and linear ecosystem challenges. Network advertising was -11%.

DIS